Given the strong positive correlation between decreased ASCL1 expression and decreased proliferation upon LSD1 and/or KDM5 inhibitor treatment7,15, we hypothesized that our screen would also uncover genes that regulate ASCL1 and neuroendocrine differentiation in SCLC. Here, ASCL1 is linked to small cell lung carcinoma.